Senior Scientist, Pharmacology
FogPharma is a biopharmaceutical company focused on developing Helicon™ therapeutics to target intracellular disease drivers. Their lead program, FOG-001, is in Phase 1/2 study for solid tumors. They are seeking a Team Facing Pharmacologist to lead in vivo studies to support FOG-001, requiring hands-on execution, CRO management, and cross-functional communication. The role involves supporting preclinical studies and regulatory filings, with opportunities for growth to contribute to clinical expansion. Successful candidates need an MS or Ph.D. in relevant fields, industry experience, and strong communication skills. FogPharma values creativity, patient focus, execution orientation, and humility. They are an equal opportunity employer promoting diversity and inclusion. The position is based in Cambridge, MA, and on-site work is required for fully vaccinated individuals, with accommodations available for those with genuine exemptions.
About the Company
Description: FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that “drug the undruggable.” FogPharma’s cell-penetrating mini proteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics. Together with world-leading experts and collaborators in cancer biology and therapy, our team is building a drug discovery powerhouse having passion, knowledge, and creativity to develop fundamentally new cancer treatments. FogPharma derives financial support from a unique syndicate of extraordinary private and institutional investors. FogPharma’s network of friends includes our founders, employees, investors, advisors, collaborators, and cancer patients; all working together to pioneer a unique approach toward conquering cancer.
Industry: Health Tech
Company Size: Medium (51-250 employees, $10M-$50M revenue)